Clinical efficiency of type-IV collagen in extracorporeal shock wave lithotripsy

Urol Int. 1995;54(3):154-6. doi: 10.1159/000282711.

Abstract

We previously reported a patient who developed anti-glomerular basement membrane antibody-induced glomerulonephritis (GBM-GN) after extracorporeal shock wave lithotripsy (ESWL). To determine whether ESWL causes anti-GBM antibody production thereby inducing GBM-GN, we measured serum levels of type-IV collagen (the most major component of GBM) before and after ESWL. Serum samples were obtained from 13 patients with renal stones and 15 with ureteral stones. The serum type-IV collagen level was determined by a radioimmunoassay method. No significant changes were observed in the type-IV collagen level after ESWL in each patient group. Type-IV collagen was abundant in the GBM but was not released into the blood after ESWL. Therefore, in patients with urinary tract stones, it is not likely that type-IV collagen, a hidden antigen in the renal glomeruli, is exposed or released into the blood after ESWL, resulting in autoantibody production and GBM-GN.

MeSH terms

  • Adult
  • Collagen / blood*
  • Female
  • Humans
  • Lithotripsy*
  • Male
  • Middle Aged
  • Radioimmunoassay
  • Ureteral Calculi / blood*
  • Ureteral Calculi / therapy

Substances

  • Collagen